ACCELERATING MEDICAL INNOVATION Trademark

Trademark Overview


On Friday, October 24, 2008, a trademark application was filed for ACCELERATING MEDICAL INNOVATION with the United States Patent and Trademark Office. The USPTO has given the ACCELERATING MEDICAL INNOVATION trademark a serial number of 77600170. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, November 16, 2019. This trademark is owned by Beaufort Advisors, LLC. The ACCELERATING MEDICAL INNOVATION trademark is filed in the Advertising, Business and Retail Services, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management

Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals

Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the...

Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and N...
accelerating medical innovation

General Information


Serial Number77600170
Word MarkACCELERATING MEDICAL INNOVATION
Filing DateFriday, October 24, 2008
Status800 - REGISTERED AND RENEWED
Status DateSaturday, November 16, 2019
Registration Number3825874
Registration DateTuesday, July 27, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2009

Trademark Statements


Goods and ServicesRegulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
Goods and ServicesConsulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals
Goods and ServicesContract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics
Goods and ServicesLegal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, June 2, 2009
Primary Code035
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, June 2, 2009
Primary Code040
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 28, 2008
Primary Code042
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 28, 2008
Primary Code045
First Use Anywhere DateThursday, June 25, 2009
First Use In Commerce DateThursday, June 25, 2009

Trademark Owner History


Party NameBEAUFORT, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNORFOLK, VA 23510

Party NameBEAUFORT, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressNORFOLK, VA 23510

Party NameBeaufort Advisors, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNorfolk, VA 23510

Party NameBeaufort Advisors, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNorfolk, VA 23510

Trademark Events


Event DateEvent Description
Saturday, November 16, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, November 16, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, November 16, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, November 16, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 9, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, July 27, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 20, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 20, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 19, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, March 19, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, March 19, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 19, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 27, 2010REGISTERED-PRINCIPAL REGISTER
Saturday, June 19, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, June 18, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, June 18, 2010ASSIGNED TO LIE
Thursday, June 3, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 19, 2010ASSIGNED TO EXAMINER
Monday, April 26, 2010STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 8, 2010USE AMENDMENT FILED
Monday, April 26, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 8, 2010TEAS STATEMENT OF USE RECEIVED
Wednesday, April 7, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 6, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 2, 2010EXTENSION 1 GRANTED
Friday, April 2, 2010EXTENSION 1 FILED
Friday, April 2, 2010TEAS EXTENSION RECEIVED
Tuesday, October 6, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2009PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2009NOTICE OF PUBLICATION
Monday, June 8, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 8, 2009ASSIGNED TO LIE
Friday, June 5, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 2, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 2, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 2, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 3, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2009NON-FINAL ACTION E-MAILED
Tuesday, February 3, 2009NON-FINAL ACTION WRITTEN
Tuesday, January 27, 2009ASSIGNED TO EXAMINER
Tuesday, October 28, 2008NEW APPLICATION ENTERED IN TRAM